Skip to main content
Glama

Data Nl

by io.github.pipeworx-io

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. First observed

TDQS

A4.7/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

The annotations already declare this tool read-only, idempotent, and non-destructive, and the description complements them by disclosing important behavior: graceful degradation if GLEIF/OpenFIGI is unavailable, returning figi_candidates when ambiguity exists, reporting unresolved identifiers explicitly, and cascading through multiple lookup endpoints. This goes well beyond the annotations and gives the agent a strong model of the tool's execution semantics.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long and dense, but the length is justified by the tool's complexity and the volume of edge-case guidance needed. It front-loads the core purpose and common example phrasings before diving into supported types and behavioral details, and nearly every clause carries substantive information.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With no output schema, the description carries the full burden of explaining what the agent will receive, and it does so thoroughly: it names the fields (CIK, ticker, company_name, LEI, FIGI, ownership info, figi_candidates), explains ambiguity behavior, and covers failure/degradation cases. The guidance on input formatting also preempts common mistakes, making the description effectively complete for an agent.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, so a baseline of 3 applies, but the description adds substantial semantics: it explains the difference between company and drug lookups, gives examples for both, lists accepted input forms (ticker, CIK, ISIN, name), and gives critical formatting guidance such as passing only the issuer name for bonds and avoiding trailing security-class words. This is far more than the schema provides.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description states a precise purpose: resolving a user-spoken name to canonical/official identifiers that other tools require. It differentiates the tool from siblings by emphasizing that it supplies IDs as input for other tools, and it enumerates entity types (company, drug) and specific identifier sources (SEC EDGAR, GLEIF, OpenFIGI, RxNorm).

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description gives explicit usage guidance: 'Use FIRST whenever you have a name but need an ID.' This clearly conveys the tool's intended role in a workflow. However, it does not name specific alternatives or describe when not to use this tool in favor of a sibling like compare_entities or entity_profile.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

All Data Nl toolsInspect
Try in Browser
RayrunBuild, deploy, and operate MCP servers without becoming an infrastructure team.ray.runAd

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.9/5.0
Disambiguation2/5

Several tool families have unclear boundaries: ask_pipeworx, ask_pipeworx_beta, and ask_pipeworx_grounded are near-duplicates (the beta is currently identical), and the six polymarket_* tools plus bet_research heavily overlap in prediction-market analysis. ai_visibility_check and scan_competitor_ai_presence also serve the same core function. An agent would frequently need to read lengthy descriptions to pick the right one, and could easily misselect.

Naming Consistency3/5

Most tools follow a readable snake_case pattern, but the style is mixed: some are verb-first (ask_pipeworx, search_datasets, resolve_entity), some are domain-prefixed nouns (polymarket_edges, pipeworx_feedback), and a few are bare nouns or adjective-noun phrases (dataset, entity_profile, recent_alerts). It is not chaotic, but there is no single predictable verb_noun convention across the set.

Tool Count2/5

With 34 tools, this is above the 25+ threshold considered too many for a coherent toolset. The count is inflated by near-duplicate families (three ask_pipeworx variants, six polymarket tools) that could reasonably be consolidated. While the server covers a broad domain, the number of top-level choices creates unnecessary selection burden for agents.

Completeness4/5

For a read-focused data/research gateway, the surface is quite complete: general lookup, grounded verification, deep research, entity resolution, comparisons, change tracking, memory, subscriptions, and feedback are all present. Minor gaps exist, such as no direct fetch-by-URI tool for the pipeworx:// citations that other tools return, and the Dutch open-data tools are strictly read-only. These are workarounds rather than dead ends.

Resources